State Ledger
Company profile

Merck & Co., Inc. CIK 310158

Ticker
MRK (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Rahway, NJ 07065
Fiscal year end
2025 (FY)
Market Data
Close
$145.46
Change
-$0.11
Change %
-0.08%
Volume
287,853

MRK · trading date Oct 12, 2026 · previous close $145.57 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$65.01B
Net income
$18.25B
Total assets
$136.87B
Total liabilities
—
Stockholders' equity
$52.61B
Cash & equivalents
$14.57B
Operating income
—
Operating cash flow
$16.47B
Capital expenditures
$4.11B

Fiscal year 2025, via 10-K filed 2026-02-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
28.1%
Free cash flow
$12.36B
Free cash flow margin
19.0%
Liabilities / assets
—
Equity / assets
38.4%
CapEx / revenue
6.3%
Operating cash flow / net income
0.90×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $65.01B $18.25B $136.87B — $52.61B
2024 $64.17B $17.12B $117.11B — $46.31B
2023 $60.12B $365.00M $106.68B — $37.58B
2022 $59.28B $14.52B $109.16B — $45.99B
2021 $48.70B $13.05B $105.69B — $38.18B
Company Details
SIC code
2834
State of incorporation
NJ
Active filer
Yes
Most recent SEC filing
Form 3
2026-09-01
Financials filed via
Form 10-K
filed 2026-02-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Rahway, NJ 07065
126 EAST LINCOLN AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies